The study demonstrates that IORT-DT is an effective treatment for liver and pancreatic tumours LPT, significantly reducing AFP and CA19-9 levels, improving liver and kidney function, lowering recurrence rates, and enhancing survival outcomes compared to conventional treatments. The gene discussed is AFP; the disease is pancreatic neoplasm.